Skip to Content
Merck
All Photos(1)

Key Documents

CLS3548

Corning® Costar® TC-Treated Multiple Well Plates

size 48 wells, polystyrene plate, flat bottom wells, case of 100 (individually wrapped), sterile, lid

Synonym(s):

cell culture plate, multi well plates, multiple well plates, multiwell plates, tissue culture plates

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
41122107
eCl@ss:
32190102
NACRES:
NB.13
material:
clear bottom
flat bottom wells
polystyrene plate
round clear wells
size:
48 wells
well diam.:
11.0 mm
well volume:
1.6 mL
well working volume:
0.19-0.285 mL
sterility:
sterile
binding type:
Tissue Culture (TC)-treated surface
feature:
lid
skirt

material

clear bottom
flat bottom wells
polystyrene plate
round clear wells

description

growth area 0.95 cm2

sterility

sterile

feature

lid
skirt

packaging

case of 100 (individually wrapped)

manufacturer/tradename

Corning 3548

size

48 wells

well diam.

11.0 mm

well volume

1.6 mL

well working volume

0.19-0.285 mL

binding type

Tissue Culture (TC)-treated surface

Looking for similar products? Visit Product Comparison Guide

General description

Rings on lid prevent cross-contamination. All plates have a uniform footprint and a raised bead to aid stacking. Alphanumerics provide well identification. Polystyrene unless stated otherwise.

Legal Information

Corning is a registered trademark of Corning, Inc.
Costar is a registered trademark of Corning, Inc.

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKBF0909

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Soni Khandelwal et al.
International journal of molecular sciences, 19(11) (2018-10-31)
Within the subtypes of breast cancer, those identified as triple negative for expression of estrogen receptor α (ESR1), progesterone receptor (PR) and human epidermal growth factor 2 (HER2), account for 10⁻20% of breast cancers, yet result in 30% of global
Soni Khandelwal et al.
Antioxidants (Basel, Switzerland), 9(2) (2020-02-09)
Previous studies have demonstrated that redox selenium compounds arrest cancer cell viability in vitro through their pro-oxidative activity by generating superoxide (O2•-). Currently, there are no efficacious treatment options for women with Triple Negative Breast Cancer (TNBC). However, the association

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service